CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Grant or award Chief Medical Officer acquired 26,900 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 26,900 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 80,750 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 26,900 shares (grant or award)
- 4 Planned sale PRESIDENT AND CEO sold 17,500 shares at an average $41.74 ($730,535)
- 4 Planned sale PRESIDENT AND CEO sold 17,500 shares at an average $43.07 ($753,680)
- 4 Planned sale PRESIDENT AND CEO sold 17,500 shares at an average $46.94 ($821,523)
- 4 Planned sale PRESIDENT AND CEO sold 19,375 shares at an average $47.98 ($929,560)
- 4 Grant or award Chief Legal Officer acquired 53,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale PRESIDENT AND CEO sold 30,625 shares at an average $49.50 ($1,516,037)
- 4 Planned sale Director sold 15,000 shares at an average $48.03 ($720,493)
- 4 Planned sale PRESIDENT AND CEO sold 19,375 shares at an average $40.39 ($782,610)
- 4 Planned sale PRESIDENT AND CEO sold 15,625 shares at an average $38.24 ($597,568)
- 4 Planned sale PRESIDENT AND CEO sold 23,125 shares at an average $46.05 ($1,064,809)
- 4 Planned sale Director sold 16,476 shares at an average $42.26 ($696,233)
- 4 Planned sale PRESIDENT AND CEO sold 15,625 shares at an average $37.50 ($585,934)
- 4 Planned sale PRESIDENT AND CEO sold 30,320 shares at an average $36.84 ($1,117,140)
- 4 Open-market sale PRESIDENT AND CEO sold 14,471 shares at $39.76 ($575,425)
- 4 Planned sale PRESIDENT AND CEO sold 15,625 shares at $37.56 ($586,927)
Page 4 of 12 · 230 filings